Open the map

IlluminaILMN

Life science tools · NASDAQ · USA

$264.57
Down 1.2% todayClose

Up 104.1% this year and +49.9% since June 26, ahead of the life science sector at +10.7%. Illumina supplies 5 mapped companies.

This year
+104.1%
1 year
+177.0%
P/E
47.1
P/S
8.6
P/B
13.7

Price vs the life science sector

since Jun 26ILMNLife science sector, equal weight
Illumina (ILMN) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ILMN: +49.9% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+20%+40%+60%Jun 26AugSepOct 8ILMN +49.9%Sector +10.7% Illumina (ILMN) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ILMN: +49.9% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+20%+40%+60%Jun 26AugSepOct 8ILMN+49.9%Sector+10.7%

Supply chain

5 customers
SUPPLIERS →→ CUSTOMERSNone mappedRegeneron (REGN)REGNRegeneron−0.3%Vertex Pharmaceuticals (VRTX)VRTXVertex Pharmaceutic…−0.5%Natera (NTRA)NTRANatera−1.2%Labcorp (LH)LHLabcorp+0.7%Quest Diagnostics (DGX)DGXQuest Diagnostics+1.7%ILMNIllumina Open the full chain →

About Illumina

DNA sequencing machines and the reagents they consume, for research and clinical genomics.

Theme exposure

Genome sequencingLife science toolsDiagnostics exposureClinical genomics

Products

  • Sequencing instruments
  • Consumables (reagents)
  • Genomics software

Competitors

  • Thermo Fisher
  • PacBio
  • MGI

Risks

  • Competition in sequencing
  • Cyclical research demand

Same segment: Life science tools

Instruments, reagents and equipment for research, development and production. Segment 5 of 8 in the Medicine, pharma & life science value chain.

Compare ILMN

Side by side with the largest companies in the same segment.

See where Illumina sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →